Uncover the next big thing with 22 elite penny stocks that balance risk and reward.
To own Genpact, you need to believe the company can steadily shift from legacy BPO toward higher value, technology led solutions while managing macro uncertainty and competition. The biggest near term catalyst remains execution in Advanced Technology Solutions, where growth and mix are central to margins. The appointment of Priya Vijayarajendran looks directionally supportive of that shift, but by itself does not materially change the key risk that AI investments may not fully offset slowing core services growth.
Among recent developments, the ongoing buyback program, with over US$2,505.91 million spent repurchasing about 74.4 million shares under the long running authorization, is particularly relevant. It highlights management’s willingness to return capital even as they reinvest heavily in AI and product platforms. For investors, this creates a direct link between Genpact’s success in scaling proprietary agentic solutions and the potential impact of those earnings on a shrinking share base.
Yet, against this push into productized AI, investors should also be aware of the growing risk that outcome based models shift more performance risk onto Genpact and...
Read the full narrative on Genpact (it's free!)
Genpact’s narrative projects $6.5 billion revenue and $754.5 million earnings by 2029. This requires 7.3% yearly revenue growth and a $171.8 million earnings increase from $582.7 million today.
Uncover how Genpact's forecasts yield a $42.18 fair value, a 11% upside to its current price.
Some of the lowest estimate analysts were already cautious, assuming revenue would reach about US$6.5 billion and earnings US$716.9 million by 2029, and they focus heavily on how rising AI talent and product engineering costs could cap margin expansion. With Vijayarajendran’s arrival, that more pessimistic view of cost pressure and execution risk around agentic platforms may be tested, so you should compare this with your own expectations for Genpact’s AI investments.
Explore 5 other fair value estimates on Genpact - why the stock might be worth 7% less than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com